No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs570787068 |
chr12:42326887-42326888 |
Bivalent/Poised TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs1234016 |
chr12:42326911-42326912 |
Bivalent/Poised TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs550466345 |
chr12:42326925-42326926 |
Bivalent/Poised TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs74896341 |
chr12:42326942-42326943 |
Bivalent/Poised TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs536050279 |
chr12:42326993-42326994 |
Bivalent/Poised TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs376904987 |
chr12:42326997-42326998 |
Bivalent/Poised TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs202174088 |
chr12:42327013-42327014 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs74079321 |
chr12:42327019-42327020 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs201579237 |
chr12:42327026-42327027 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs201879656 |
chr12:42327027-42327028 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs566220140 |
chr12:42327094-42327095 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs539828482 |
chr12:42327095-42327096 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs150301066 |
chr12:42327210-42327211 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs137974044 |
chr12:42327252-42327253 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs4516032 |
chr12:42327254-42327255 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs1968132 |
chr12:42327261-42327262 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs544147084 |
chr12:42327264-42327265 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs11181256 |
chr12:42327267-42327268 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs556433382 |
chr12:42327296-42327297 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs12579248 |
chr12:42327311-42327312 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|